Health
Results: 4105-4116 of 8221

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis






